270: Your guide to Wegovy’s blockbuster heart study
The Readout Loud
00:00
The Wall Street Side of Obesity
Eli Lilly's stock price ripped higher this week, propelling the drug maker's market value to an otherworldly $500 billion. Jared Holtz is a biotech strategist at Mizzou host Securities. He says for the first time, we're looking at a stock that may have momentum for the next five to 10 years.
Transcript
Play full episode
